1. Home
  2. PCVX vs SON Comparison

PCVX vs SON Comparison

Compare PCVX & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • SON
  • Stock Information
  • Founded
  • PCVX 2013
  • SON 1899
  • Country
  • PCVX United States
  • SON United States
  • Employees
  • PCVX 414
  • SON N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • SON Containers/Packaging
  • Sector
  • PCVX Health Care
  • SON Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • SON Nasdaq
  • Market Cap
  • PCVX 4.1B
  • SON 4.5B
  • IPO Year
  • PCVX 2020
  • SON N/A
  • Fundamental
  • Price
  • PCVX $35.02
  • SON $44.71
  • Analyst Decision
  • PCVX Strong Buy
  • SON Strong Buy
  • Analyst Count
  • PCVX 10
  • SON 7
  • Target Price
  • PCVX $136.50
  • SON $57.43
  • AVG Volume (30 Days)
  • PCVX 2.5M
  • SON 694.9K
  • Earning Date
  • PCVX 05-07-2025
  • SON 07-30-2025
  • Dividend Yield
  • PCVX N/A
  • SON 4.74%
  • EPS Growth
  • PCVX N/A
  • SON N/A
  • EPS
  • PCVX N/A
  • SON 1.54
  • Revenue
  • PCVX N/A
  • SON $5,705,957,000.00
  • Revenue This Year
  • PCVX N/A
  • SON $47.17
  • Revenue Next Year
  • PCVX N/A
  • SON N/A
  • P/E Ratio
  • PCVX N/A
  • SON $28.99
  • Revenue Growth
  • PCVX N/A
  • SON 13.66
  • 52 Week Low
  • PCVX $27.66
  • SON $39.46
  • 52 Week High
  • PCVX $121.06
  • SON $61.73
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 52.30
  • SON 46.39
  • Support Level
  • PCVX $31.37
  • SON $44.89
  • Resistance Level
  • PCVX $33.31
  • SON $46.83
  • Average True Range (ATR)
  • PCVX 2.13
  • SON 0.84
  • MACD
  • PCVX 0.77
  • SON -0.05
  • Stochastic Oscillator
  • PCVX 77.80
  • SON 21.88

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About SON Sonoco Products Company

Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.

Share on Social Networks: